SUBSCRIBE
SUBSCRIBE
News   Business

Springboard Taps New Fund For Axogen $7.75M Series B

March 1, 2006 | 
1 min read
/1/2006 – Florida early-stage investor Springboard Capital said it has made a first investment from its second hybrid angel/VC fund, contributing to a $7.75 million Series B round of AxoGen Inc., a developer of nerve grafts.
Startups
MORE ON THIS TOPIC
Words IPO (Initial public offering) with the trading data on the background.
IPO
2026 IPO stock tracker: How newly public biotechs are performing
August 19, 2026
 · 
1 min read
 · 
Gabrielle Masson
FDA
Amylyx’s redemption story, Summit’s survival woes, Definium’s anxiety win, more
August 19, 2026
 · 
2 min read
 · 
Jef Akst
Business negotiation, deal making or acquisition, merger vector concept. Two men shaking hands. Minimal design. Eps10 illustration
Manufacturing
Sandoz inks $322M Henlius deal for rights to as many as 10 biosimilars
August 18, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Balloons in the cloudy sky paper cutting art Sky background clouds, scene 3D illustration
Dermatology
LEO adds to dermatology portfolio with $435M deal for late-stage rare disease drug
August 18, 2026
 · 
1 min read
 · 
Annalee Armstrong